ITPCru ceases its participation in the EECA CAB in favor of its own project activities and from now on work of the EECA CAB will be coordinated by the ECUO. Note that …
EECA CAB and GILEAD meeting took place in Kyiv on November 22, 2016. We express our great gratitude to GILEAD for supporting this format of the meeting and for discussing …
EECA CAB and CIPLA meeting took place in Kyiv on November 21, 2016. We express our great gratitude to CIPLA for supporting this format of the meeting and for discussing the …
We are glad to present you EECA CAB and MPP meeting minutes which took place in the end of May 2015. Access to treatment of HIV, hepatitis C and TB issues …
February 24, 2015, Medicines Patent Pool announced a license agreement with Merck Sharp & Dohme Corp. and MSD Italia s.r.l. (collectively «Merck») for pediatric raltegravir. From the EECA region, the following countries were …
The EECA CAB and Gilead Sciences meeting minutes, which was held in October 2014 in Tbilisi, are available. The issues of access to medicines for the treatment of HIV and hepatitis C (registration, pricing policy, voluntary …
Representatives of patient organizations and access to treatment activists from EECA countries met ViiV Healthcare in October, 2014. The issues of access to existing products on the market were raised (registration, pricing policy) as well as new developments …
EECA CAB addressed to BMS to respond to the company’s access policy related to hepatitis C drugs. Activists expressed their position in regards to that fact that only 4 countries from the region are included in the strategy.
We are glad to present you EECA CAB and Medicines patent pool meeting minutes. The meeting took place in St. Petersburg, June 30, 2014.
EECA CAB meeting minutes was published. During the meeting (June, 30th, 2014, St.-Petersburg) patients’ community disscussed with MSD representatives the following access issues: what are the next plan of the company …
Estimated numbers on Hepatitis C show that 4-8 million people live with HCV in EECA region. However the last assessment of the situation with HCV in EECA countries was done in 2008-2009; and official data on the …
EECA CAB and Janssen meeting minutes are published. During the meeting which took place in Saint-Petersburg in July 2014 access issues were discussed including company’s drugs registration in EECA countries, pricing policy etc.
